marketcap
Facebook
Twitter
Telegram
Report an ErrorAnnual report 2024
added 02-26-2025
United Therapeutics Corporation Financial Ratios 2011-2025 | UTHR
Annual Financial Ratios United Therapeutics Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
12.0 | 10.3 | 15.3 | 15.7 | 14.4 | -40.4 | 8.6 | 14.3 | 9.8 | 8.7 | 20.0 | 30.5 | 9.2 | 13.0 |
P/S |
5.0 | 4.4 | 5.7 | 4.4 | 5.0 | 2.9 | 3.1 | 3.5 | 4.4 | 3.9 | 5.3 | 4.8 | 3.0 | 3.8 |
EPS |
26.4 | 21.0 | 16.0 | 10.6 | 11.7 | -2.4 | 13.5 | 9.5 | 16.3 | 14.2 | 7.1 | 3.5 | 5.8 | 3.8 |
EV (Enterprise Value) |
13.5 B | 10.1 B | 11.4 B | 7.78 B | 7.87 B | 4.61 B | 4.98 B | 6.04 B | 6.43 B | 5.42 B | 7.02 B | 5.82 B | 3.16 B | 3.24 B |
EBITDA per Share |
32.1 | 26.5 | 22.7 | 13.5 | 14.6 | -3.24 | 19.3 | 24 | 25 | 15.9 | 11.9 | 6.47 | 8.62 | 5.92 |
EV/EBITDA |
12.8 | 10.1 | -30.6 | 5.5 | 5.2 | 5.5 | 6.6 | 11.4 | 16.5 | 6.5 | 8.5 | |||
PEG |
-0.13 | -0.09 | -0.12 | -0.11 | -0.11 | 0.34 | 0.2 | -0.34 | 0.65 | 0.09 | 0.2 | -0.76 | 0.17 | 0.13 |
P/B |
2.2 | 1.7 | 2.3 | 1.9 | 2.2 | 1.5 | 1.8 | 2.8 | 3.8 | 3.5 | 5.4 | 4.1 | 2.5 | 3.0 |
P/CF |
10.8 | 10.4 | 13.8 | 12.5 | 9.8 | -14.5 | 8.5 | 15.4 | 11.6 | 17.0 | 22.1 | 13.5 | 13.2 | 13.2 |
ROE % |
18.55 | 16.46 | 15.16 | 12.02 | 15.16 | -3.76 | 20.98 | 19.70 | 38.33 | 40.74 | 26.87 | 13.38 | 27.81 | 22.97 |
ROA % |
16.23 | 13.74 | 12.03 | 9.20 | 11.15 | -2.67 | 17.32 | 14.51 | 30.69 | 29.83 | 18.05 | 8.36 | 18.72 | 14.35 |
ROCE % |
21.37 | 19.80 | 20.42 | 14.04 | 17.48 | -5.44 | 25.78 | 42.10 | 53.27 | 40.09 | 39.04 | 20.89 | 29.08 | 24.34 |
Current Ratio |
8.0 | 6.1 | 4.8 | 4.3 | 3.8 | 4.0 | 6.4 | 3.3 | 4.3 | 2.9 | 1.9 | 1.3 | 3.8 | 2.6 |
DSO |
35.4 | 39.2 | 39.5 | 38.6 | 38.0 | 38.1 | 39.4 | 62.9 | 49.0 | 48.0 | 46.0 | 41.3 | 46.5 | 43.6 |
DIO |
158.9 | 151.5 | 235.7 | 268.6 | 303.7 | 289.9 | 185.5 | 372.6 | 502.1 | 430.0 | 194.1 | 132.9 | 114.0 | 188.8 |
DPO |
6.8 | 6.9 | 9.5 | 11.8 | 23.6 | 30.7 | 42.4 | 29.0 | 40.7 | 39.7 | 20.3 | 18.7 | 31.2 | 194.0 |
Operating Cycle |
194.3 | 190.7 | 275.2 | 307.2 | 341.7 | 328.0 | 224.9 | 435.5 | 551.0 | 478.0 | 240.0 | 174.2 | 160.5 | 232.3 |
Cash Conversion Cycle |
187.5 | 183.8 | 265.7 | 295.4 | 318.1 | 297.3 | 182.5 | 406.4 | 510.4 | 438.4 | 219.7 | 155.5 | 129.2 | 38.3 |
All numbers in USD currency
Quarterly Financial Ratios United Therapeutics Corporation
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
6.93 | 6.26 | 6.52 | - | 5.71 | 5.53 | 5.2 | - | 5.26 | 2.56 | 5.31 | - | 3.62 | 3.85 | 0.63 | - | 3.86 | 2.43 | 3.14 | 1.2 | 3.02 | 4.68 | -11.32 | 1.5 | 2.44 | 4.01 | 5.65 | 0.44 | 6.37 | -1.25 | 4.01 | 2.61 | 3.75 | 4.65 | 5.19 | 2.29 | 10.2 | 2.15 | -0.36 | 2.44 | -0.53 | 2.35 | 2.73 | -0.6 | 1.25 | 1.6 | 1.24 | 1.65 | 1.52 | 1.37 | 1.32 | 0.79 | 1.45 | 1.27 | 0.28 |
EBITDA per Share |
- | - | 7.9 | - | - | - | 6.43 | - | 7.75 | 4.44 | 6.65 | - | 5.92 | 4.96 | -1.17 | - | 5.81 | 3.75 | 4.08 | - | 4.94 | 5.53 | -14.8 | - | 4.01 | 5.42 | 7.27 | - | 8 | 2.32 | 6.1 | - | 6.07 | 6.79 | 8.18 | - | 9.05 | 4.09 | -0.14 | - | -0.19 | 4.02 | 4.44 | - | 2.56 | 2.77 | 2.04 | - | 1.95 | 2.25 | 2.11 | - | 2.03 | 2.15 | 0.74 |
ROE % |
20.38 | 19.99 | 19.90 | 14.18 | 19.42 | 19.98 | 17.88 | 13.68 | 17.92 | 16.93 | 18.98 | 9.81 | 14.85 | 15.65 | 14.06 | 12.25 | 14.14 | 13.86 | 18.09 | -3.76 | -3.31 | 10.72 | 18.31 | 44.86 | 43.43 | 43.62 | 34.48 | 34.21 | 39.27 | 52.88 | 70.90 | 75.13 | 75.75 | 72.39 | 54.78 | 41.02 | 43.76 | 12.50 | 15.26 | 27.37 | 15.63 | 22.64 | 19.98 | 13.86 | 23.95 | 26.18 | 26.51 | 28.09 | 24.96 | 26.65 | 27.77 | 22.97 | 8.90 | 7.79 | 1.73 |
ROA % |
17.01 | 16.48 | 16.22 | 11.49 | 15.62 | 15.95 | 16.55 | 13.09 | 16.31 | 10.92 | 14.48 | 7.39 | 11.10 | 11.59 | 10.35 | 9.01 | 10.36 | 10.03 | 12.95 | -2.67 | -2.09 | 9.93 | 16.96 | 36.79 | 35.53 | 33.98 | 25.96 | 24.97 | 29.06 | 41.15 | 55.88 | 59.80 | 59.85 | 55.16 | 40.72 | 29.83 | 31.19 | 8.59 | 9.99 | 18.05 | 10.44 | 14.78 | 12.67 | 8.36 | 14.93 | 16.73 | 17.35 | 18.72 | 16.44 | 17.20 | 17.62 | 14.35 | 5.56 | 4.87 | 1.08 |
ROCE % |
- | - | - | - | 6.89 | 13.78 | 18.45 | 18.46 | 24.43 | 23.51 | 24.94 | 10.20 | 16.71 | 17.25 | 15.28 | 15.56 | 22.16 | 22.24 | 26.07 | -9.03 | -3.67 | -4.90 | -5.06 | 24.17 | 39.16 | 48.79 | 45.10 | 31.64 | 44.52 | 42.42 | 52.71 | 46.92 | 71.28 | 82.76 | 79.18 | 34.24 | 31.65 | 4.69 | 8.07 | 29.00 | 37.31 | 48.21 | 43.73 | 25.49 | 32.94 | 32.07 | 32.10 | 27.03 | 37.89 | 41.30 | 43.63 | 26.81 | 10.86 | 12.07 | 3.88 |
Current Ratio |
7.0 | 6.5 | 5.6 | 6.1 | 5.4 | 5.3 | 5.2 | 4.8 | 4.7 | - | 4.5 | 4.3 | 4.1 | 4.0 | 3.9 | 3.8 | 3.8 | 3.8 | 3.8 | 3.5 | 3.5 | 3.5 | 3.5 | 5.7 | 5.7 | 5.7 | 5.7 | 3.8 | 3.8 | 3.8 | 3.8 | 5.0 | 5.0 | 5.0 | 5.0 | 3.7 | 3.7 | 3.7 | 3.7 | 3.0 | 3.0 | 3.0 | 3.0 | 2.7 | 2.7 | 2.7 | 2.7 | 3.1 | 3.1 | 3.1 | 3.1 | 2.7 | 2.7 | 2.7 | 2.7 |
DSO |
38.5 | 38.2 | 39.5 | - | 39.8 | 31.1 | 31.9 | - | 20.5 | 16.7 | 36.5 | - | 39.6 | 32.1 | 35.9 | - | 37.8 | 39.7 | 39.5 | 44.4 | 34.4 | 37.0 | 41.2 | 42.0 | 38.9 | 36.1 | 55.4 | 58.3 | 60.9 | 61.0 | 63.0 | 47.9 | 48.0 | 47.4 | 50.4 | 43.5 | 45.5 | 50.7 | 49.5 | 42.8 | 44.9 | 45.9 | 45.5 | 39.9 | 38.1 | 41.1 | 45.2 | 43.6 | 43.9 | 47.2 | 45.9 | 41.5 | 40.1 | 44.0 | - |
DIO |
155.5 | 150.5 | 145.2 | - | 135.1 | 146.5 | 178.4 | - | 111.6 | 135.5 | 320.6 | - | 307.4 | 223.3 | 354.5 | - | 328.9 | 304.8 | 350.8 | 295.9 | 258.3 | 319.2 | 304.8 | 288.9 | 177.6 | 149.4 | 179.2 | 185.8 | 504.9 | 521.0 | 663.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | 6.7 | - | - | - | 8.1 | - | - | - | 19.3 | 15.7 | - | - | 36.2 | 33.0 | - | - | 7.2 | 7.2 | - | - | 25.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
194.0 | 188.7 | 184.7 | - | 174.9 | 177.6 | 210.3 | - | 132.1 | 152.2 | 357.1 | - | 347.0 | 255.5 | 390.4 | - | 366.7 | 344.4 | 390.3 | 340.3 | 292.7 | 356.2 | 345.9 | 330.9 | 216.4 | 185.4 | 234.6 | 244.1 | 565.8 | 581.9 | 726.3 | 47.9 | 48.0 | 47.4 | 50.4 | 43.5 | 45.5 | 50.7 | 49.5 | 42.8 | 44.9 | 45.9 | 45.5 | 39.9 | 38.1 | 41.1 | 45.2 | 43.6 | 43.9 | 47.2 | 45.9 | 41.5 | 40.1 | 44.0 | - |
Cash Conversion Cycle |
194.0 | 188.7 | 184.7 | - | 174.9 | 177.6 | 210.3 | - | 132.1 | 152.2 | 350.4 | - | 347.0 | 255.5 | 382.3 | - | 366.7 | 344.4 | 371.0 | 324.7 | 292.7 | 356.2 | 309.7 | 297.9 | 216.4 | 185.4 | 227.4 | 236.9 | 565.8 | 581.9 | 700.5 | 47.9 | 48.0 | 47.4 | 50.4 | 43.5 | 45.5 | 50.7 | 49.5 | 42.8 | 44.9 | 45.9 | 45.5 | 39.9 | 38.1 | 41.1 | 45.2 | 43.6 | 43.9 | 47.2 | 45.9 | 41.5 | 40.1 | 44.0 | - |
All numbers in USD currency